[go: up one dir, main page]

AU1682400A - 4-oxoimidazolidine-2-spiro-nitrogenous heterocycle compounds - Google Patents

4-oxoimidazolidine-2-spiro-nitrogenous heterocycle compounds

Info

Publication number
AU1682400A
AU1682400A AU16824/00A AU1682400A AU1682400A AU 1682400 A AU1682400 A AU 1682400A AU 16824/00 A AU16824/00 A AU 16824/00A AU 1682400 A AU1682400 A AU 1682400A AU 1682400 A AU1682400 A AU 1682400A
Authority
AU
Australia
Prior art keywords
oxoimidazolidine
spiro
heterocycle compounds
nitrogenous heterocycle
nitrogenous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU16824/00A
Inventor
Yoshiki Ito
Yoshikazu Iwasawa
Hiroshi Kawamoto
Satoshi Ozaki
Atsushi Satoh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSD KK
Original Assignee
Banyu Phamaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Phamaceutical Co Ltd filed Critical Banyu Phamaceutical Co Ltd
Publication of AU1682400A publication Critical patent/AU1682400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Addiction (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU16824/00A 1998-12-09 1999-12-09 4-oxoimidazolidine-2-spiro-nitrogenous heterocycle compounds Abandoned AU1682400A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP35058398 1998-12-09
JP10/350583 1998-12-09
PCT/JP1999/006921 WO2000034280A1 (en) 1998-12-09 1999-12-09 4-oxoimidazolidine-2-spiro-nitrogenous heterocycle compounds

Publications (1)

Publication Number Publication Date
AU1682400A true AU1682400A (en) 2000-06-26

Family

ID=18411469

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16824/00A Abandoned AU1682400A (en) 1998-12-09 1999-12-09 4-oxoimidazolidine-2-spiro-nitrogenous heterocycle compounds

Country Status (2)

Country Link
AU (1) AU1682400A (en)
WO (1) WO2000034280A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001262729A1 (en) * 2000-06-14 2001-12-24 Banyu Pharmaceutical Co., Ltd 4-oxoimidazolidine-2-spiro-nitrogenous heterocycle compounds
US7192964B2 (en) 2001-07-23 2007-03-20 Banyu Pharmaceutical Co., Ltd. 4-oxoimidazolidine-2-spiropiperidine derivatives
WO2003095427A1 (en) * 2002-05-10 2003-11-20 Taisho Pharmaceutical Co.,Ltd. Spiro-ring compound
DE102004014296A1 (en) * 2004-03-22 2005-10-06 Grünenthal GmbH Substituted 1,4,8-triazaspiro [4.5] decan-2-one compounds
DE102004014304A1 (en) * 2004-03-22 2005-10-06 Grünenthal GmbH Substituted 1,4,8-triazaspiro [4,5] decan-2-one compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3725389A (en) * 1971-07-02 1973-04-03 American Home Prod Adducts of delta-aminobenzylpenicillin and n-substituted-4-piperidones

Also Published As

Publication number Publication date
WO2000034280A1 (en) 2000-06-15

Similar Documents

Publication Publication Date Title
AU1978699A (en) Heterocyclic compounds
AU5546000A (en) Compounds
AU2863899A (en) New compounds
AU4580599A (en) Stable no-delivering compounds
AU4260199A (en) Novel compounds
AU1424200A (en) Compounds
AU4501699A (en) Aminoazole compounds
AU5980899A (en) Novel compounds
AU2014800A (en) Novel compounds
AU3997700A (en) Anti-first-pass effect compounds
AU1746401A (en) Compounds
AU6032100A (en) New compounds
AU1434500A (en) Compounds
AU4814699A (en) Novel compounds
AU6228299A (en) 2-substituted-d-homooxasteroid derivatives
AU1682400A (en) 4-oxoimidazolidine-2-spiro-nitrogenous heterocycle compounds
AU2187799A (en) Novel taxaneterpine compounds
AU2640999A (en) 1-azaindolizine derivatives
AU3730699A (en) Heterocyclic compound
AU2863799A (en) New compounds
AU2894099A (en) Phenanthrofuran derivatives
AU5239899A (en) Amidophosphate derivatives
AU4141099A (en) Pyrazolyldioxothiochromanoyl derivatives
AU2725599A (en) Substituted alxoxycarbonyl compounds
AU5119400A (en) Compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase